• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为CRK3激酶抑制剂且具有体外抗利什曼原虫活性的2,6,9-三取代嘌呤

2,6,9-Trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro.

作者信息

Řezníčková Eva, Popa Alexandr, Gucký Tomáš, Zatloukal Marek, Havlíček Libor, Bazgier Václav, Berka Karel, Jorda Radek, Popa Igor, Nasereddin Abdelmajeed, Jaffe Charles L, Kryštof Vladimír, Strnad Miroslav

机构信息

Laboratory of Growth Regulators & Department of Chemical Biology and Genetics, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University and Institute of Experimental Botany AS CR, Šlechtitelů 11, 783 71 Olomouc, Czech Republic.

Laboratory of Growth Regulators & Department of Chemical Biology and Genetics, Centre of the Region Haná for Biotechnological and Agricultural Research, Palacký University and Institute of Experimental Botany AS CR, Šlechtitelů 11, 783 71 Olomouc, Czech Republic; Department of Physical Chemistry, Faculty of Science, Palacký University, 17. listopadu 1192/12, 771 46 Olomouc, Czech Republic.

出版信息

Bioorg Med Chem Lett. 2015 Jun 1;25(11):2298-301. doi: 10.1016/j.bmcl.2015.04.030. Epub 2015 Apr 16.

DOI:10.1016/j.bmcl.2015.04.030
PMID:25937014
Abstract

Here we describe the leishmanicidal activities of a library of 2,6,9-trisubstituted purines that were screened for interaction with Cdc2-related protein kinase 3 (CRK3) and subsequently for activity against parasitic Leishmania species. The most active compound inhibited recombinant CRK3 with an IC50 value of 162 nM and was active against Leishmania major and Leishmania donovani at low micromolar concentrations in vitro. Its mode of binding to CRK3 was investigated by molecular docking using a homology model.

摘要

在此,我们描述了一个2,6,9-三取代嘌呤文库的杀利什曼原虫活性,该文库经筛选与Cdc2相关蛋白激酶3(CRK3)相互作用,随后检测其对寄生利什曼原虫物种的活性。活性最强的化合物对重组CRK3的IC50值为162 nM,在低微摩尔浓度下对硕大利什曼原虫和杜氏利什曼原虫具有体外活性。使用同源模型通过分子对接研究了其与CRK3的结合模式。

相似文献

1
2,6,9-Trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro.作为CRK3激酶抑制剂且具有体外抗利什曼原虫活性的2,6,9-三取代嘌呤
Bioorg Med Chem Lett. 2015 Jun 1;25(11):2298-301. doi: 10.1016/j.bmcl.2015.04.030. Epub 2015 Apr 16.
2
Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase: chemical library screen and antileishmanial activity.墨西哥利什曼原虫CRK3细胞周期蛋白依赖性激酶抑制剂:化学文库筛选及抗利什曼原虫活性
Antimicrob Agents Chemother. 2004 Aug;48(8):3033-42. doi: 10.1128/AAC.48.8.3033-3042.2004.
3
High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinase.高通量筛选得到了抑制利什曼原虫 CRK3:CYC6 周期蛋白依赖性激酶的小分子抑制剂。
PLoS Negl Trop Dis. 2011 Apr 5;5(4):e1033. doi: 10.1371/journal.pntd.0001033.
4
Structure based medicinal chemistry-driven strategy to design substituted dihydropyrimidines as potential antileishmanial agents.基于结构的药物化学驱动策略设计取代二氢嘧啶作为潜在抗利什曼原虫药物。
Eur J Med Chem. 2016 Jun 10;115:230-44. doi: 10.1016/j.ejmech.2016.03.022. Epub 2016 Mar 14.
5
Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.新型呋喃基和噻吩基唑类化合物的合成与评价及其抗利什曼原虫活性。
Eur J Med Chem. 2011 May;46(5):1694-700. doi: 10.1016/j.ejmech.2011.02.021. Epub 2011 Feb 22.
6
Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.设计、合成及生物评价芳基嘧啶衍生物作为潜在的抗利什曼原虫药物。
Bioorg Med Chem Lett. 2013 Sep 15;23(18):5235-8. doi: 10.1016/j.bmcl.2013.06.060. Epub 2013 Jun 29.
7
Anti-leishmanial activity of disubstituted purines and related pyrazolo[4,3-d]pyrimidines.二取代嘌呤和相关吡唑并[4,3-d]嘧啶的抗利什曼原虫活性。
Bioorg Med Chem Lett. 2011 Jul 15;21(14):4233-7. doi: 10.1016/j.bmcl.2011.05.076. Epub 2011 May 27.
8
Synthesis and biological evaluation of ferrocenylquinoline as a potential antileishmanial agent.二茂铁基喹啉作为潜在抗利什曼原虫剂的合成及生物学评价
ChemMedChem. 2015 Mar;10(3):546-54. doi: 10.1002/cmdc.201402537. Epub 2015 Jan 23.
9
Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani.靶向杜氏利什曼原虫的2-芳基苯并咪唑的合成与生物学评价
Bioorg Med Chem Lett. 2015 May 1;25(9):1933-7. doi: 10.1016/j.bmcl.2015.03.027. Epub 2015 Mar 18.
10
Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines.新型2,4,6-三取代嘧啶和1,3,5-三嗪的合成及其抗利什曼原虫活性
Eur J Med Chem. 2009 Jun;44(6):2473-81. doi: 10.1016/j.ejmech.2009.01.016. Epub 2009 Jan 27.

引用本文的文献

1
Protein Kinases: Important Regulators of the Parasite Life Cycle and Molecular Targets for Treating Leishmaniasis.蛋白激酶:寄生虫生命周期的重要调节因子及治疗利什曼病的分子靶点
Microorganisms. 2021 Mar 27;9(4):691. doi: 10.3390/microorganisms9040691.
2
and Characterization of Potent Antileishmanial Methionine Aminopeptidase 1 Inhibitors.并对强效抗利什曼原虫蛋氨酸氨肽酶 1 抑制剂进行了表征。
Antimicrob Agents Chemother. 2020 May 21;64(6). doi: 10.1128/AAC.01422-19.
3
Unveiling the Kinomes of and Empowers the Discovery of New Kinase Targets and Antileishmanial Compounds.
揭示[具体对象1]和[具体对象2]的激酶组有助于发现新的激酶靶点和抗利什曼原虫化合物。 (原文中两个“and”后内容缺失,以上为补全后符合语境的翻译)
Comput Struct Biotechnol J. 2019 Feb 8;17:352-361. doi: 10.1016/j.csbj.2019.02.005. eCollection 2019.
4
Ruthenium-Clotrimazole complex has significant efficacy in the murine model of cutaneous leishmaniasis.钌-克霉唑复合物在皮肤利什曼病的小鼠模型中具有显著疗效。
Acta Trop. 2016 Dec;164:402-410. doi: 10.1016/j.actatropica.2016.09.029. Epub 2016 Sep 30.
5
Conditional gene deletion with DiCre demonstrates an essential role for CRK3 in Leishmania mexicana cell cycle regulation.利用DiCre进行条件性基因缺失证明了CRK3在墨西哥利什曼原虫细胞周期调控中起关键作用。
Mol Microbiol. 2016 Jun;100(6):931-44. doi: 10.1111/mmi.13375. Epub 2016 Apr 13.